Mimio Health
Welcome to Fasting 2.0
Founded 2020 · $1.8M raised
- Employees
- 1–10
- Founded
- 2020
- Website
- mimiohealth.com
- Total Funding
- $1.8M
- Last Round
- $1.8M SeedMar 2023
- Rounds
- 1
About
Mimio Health is a nutraceutical company pioneering the world's first fasting mimetic supplement, designed from seven years of human clinical research to replicate the cellular health and longevity benefits of a 36-hour fast without requiring dietary restriction. The company's patent-pending formulation delivers a rigorously selected combination of bioactive fasting metabolites that activate the body's natural cellular repair pathways — including autophagy, AMPK, and SIRT — to reduce biological age, support healthy glucose and cholesterol levels, and improve energy and cognitive performance. Mimio has demonstrated a 96% lifespan extension in model organisms and has been featured in Rolling Stone, TechCrunch, Men's Journal, and Vogue. Products are vegan, gluten-free, GMO-free, GMP-certified, and sold direct-to-consumer.
Summary
Mimio Health is a company, founded in 2020. It has raised $1.8M in total across 1 round, most recently a $1.8M Seed round in Mar 2023. Investors include better ventures, 10X Capital and AgFunder.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2023
